Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II randomized dose-finding study of SAR443122 in adults with moderate to severe ulcerative colitis
CTR20231473Phase 2Active
- Sponsor
- Sanofi
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of eclitasertib in autoimmune colitis, sponsored by Sanofi. Started Jan 2024; status: active.
02
Drugs
eclitasertib
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on CTR20231473.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20231473.